| Full text | |
| Author(s): |
Total Authors: 2
|
| Affiliation: | [1] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Struct & Funct Biol, Rua Monteiro Lobato 255, CP 6109, BR-13083862 Sao Paulo - Brazil
Total Affiliations: 1
|
| Document type: | Journal article |
| Source: | BMC CANCER; v. 16, JUL 7 2016. |
| Web of Science Citations: | 17 |
| Abstract | |
Background: Cancer-cachexia state frequently induces both fat and protein wasting, leading to death. In this way, the knowledge of the mechanism of drugs and their side effects can be a new feature to treat and to have success, contributing to a better life quality for these patients. Metformin is an oral drug used in type 2 diabetes mellitus, showing inhibitory effect on proliferation in some neoplastic cells. For this reason, we evaluated its modulatory effect on Walker-256 tumour evolution and also on protein metabolism in gastrocnemius muscle and body composition. Methods: Wistar rats received or not tumour implant and metformin treatment and were distributed into four groups, as followed: control (C), Walker 256 tumour-bearing (W), metformin-treated (M) and tumour-bearing treated with metformin (WM). Animals were weighed three times a week, and after cachexia state has been detected, the rats were euthanised and muscle and tumour excised and analysed by biochemical and molecular assays. Results: Tumour growth promoted some deleterious effects on chemical body composition, increasing water and decreasing fat percentage, and reducing lean body mass. In muscle tissue, tumour led to a decreased protein synthesis and an increased proteolysis, showing the higher activity of the ubiquitin-proteasome pathway. On the other hand, the metformin treatment likely minimised the tumour-induced wasting state; in this way, this treatment ameliorated chemical body composition, reduced the higher activities of proteolytic enzymes and decreased the protein waste. Conclusion: Metformin treatment not only decreases the tumour growth but also improves the protein metabolism in gastrocnemius muscle in tumour-bearing rats. (AU) | |
| FAPESP's process: | 08/07737-0 - Effects of metformin treatment associated to leucine rich-diet on protein metabolism in tumour-bearing rats. |
| Grantee: | André Gustavo de Oliveira |
| Support Opportunities: | Scholarships in Brazil - Master |
| FAPESP's process: | 14/13334-7 - Nutrition and Cancer - Metabolomic, and proteomic profile of muscle, placental, fetal, and tumor cell signaling pathways, in Walker-256 tumour-bearing pregnant rats submitted to leucine nutritional supplementation. |
| Grantee: | Maria Cristina Cintra Gomes Marcondes |
| Support Opportunities: | Regular Research Grants |
| FAPESP's process: | 13/16115-1 - Biochemical and molecular mechanisms of cachexia. Effects of Walker Factor and leucine supplementation on myotube cell culture. |
| Grantee: | Maria Cristina Cintra Gomes Marcondes |
| Support Opportunities: | Regular Research Grants |
| FAPESP's process: | 10/00209-9 - Nutritional supplementation and Cancer Cachexia. Biochemical and Molecular studies. |
| Grantee: | Maria Cristina Cintra Gomes Marcondes |
| Support Opportunities: | Regular Research Grants |